SEPN
SEPN
NASDAQ · Pharmaceuticals

Septerna Inc

$47.35
-0.53 (-1.11%)
As of Nov 7, 1:53 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -5.0% upside
Low Target $33.78
Average Target $44.96
High Target $58.81
Current Price $47.35
Current
$47.35
Target
$44.96
$33.78 $44.96 avg $58.81
Scenario Analysis
Bear Case
$33.78
-28.7%
Low target
Base Case
$44.96
-5.0%
Avg target
Bull Case
$58.81
+24.2%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$51.10
-7.3% from high
52-Week Low
$17.55
+169.8% from low
Target vs 52W High
$44.96
-12.0% vs high
Next Earnings Report
Nov 25, 2026
17d
until earnings
EPS Est: $-0.42
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%